Product Details
| Product Name:
Sinbaglustat |
CAS No.:
441061-33-2 |
| Purity:
99.93% |
Supply Ability:
10g |
| Release date:
2025/07/09 |
Product Introduction
Bioactivity
| Name | Sinbaglustat |
| Description | Sinbaglustat (OGT2378) (OGT2378) is a dual inhibitor of glucose ceramide synthetase (GCS) and non-lysosomal glucose ceramidase (GBA2).Sinbaglustat is an orally administered N-alkyl iminosugar that crosses the blood-brain barrier.Sinbaglustat is used for the treatment of lysosomal storage disorders and for the study of central neurodegenerative disorders associated with lysosomal dysfunction. Sinbaglustat is used for the treatment of lysosomal storage disorders and for the study of lysosomal dysfunction-related central neurodegenerative diseases. |
| In vitro | Sinbaglustat (OGT2378) (20 μM) leads to a remarkable reduction in the synthesis of glucosylceramide by 93% and ganglioside by >95% when compared to untreated MEB4 cells. This reduction occurs without inducing any cytotoxicity or antiproliferative effects.[1]
Sinbaglustat is 50-fold more potent in inhibiting GBA2 than GCS.[2] |
| In vivo | Sinbaglustat (OGT2378) (2500 mg/kg/day; p.o.; in the powdered chow; corresponding to 35-40 mg/mouse/day of Sinbaglustat; Female syngeneic C57BL/6 mice and bearing MEB4 melanoma tumor, 6-8 weeks old bearing MEB4 melanoma tumor) is highly effective in impeding melanoma tumor growth in vivo. The effectiveness of p.o. Sinbaglustat in this murine model suggests that inhibition of glycosphingolipid synthesis is a promising approach to inhibit tumor progression.[1] |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 46.66 mg/mL (200 mM), Sonication is recommended.
|
| Keywords | OGT-2378 | OGT 2378 | glucosylceramide synthase | ACT519276 | ACT 519276 |
| Inhibitors Related | Alendronate sodium trihydrate | Serotonin hydrochloride | Rosmarinic acid | Risedronate Sodium | Risedronic Acid | 3-Methoxybenzamide | Entacapone | CBHcy | OU749 | Ibandronate sodium | Testosterone propionate | Flopropione |
| Related Compound Libraries | Bioactive Compound Library | CNS-Penetrant Compound Library | Inhibitor Library | Metabolism Compound Library | Orally Active Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:115939-25-8
$210.00 / 25mg
-
CAS:1239278-59-1
$233.00 / 1mg
-
CAS:28448-85-3
$47.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States